BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 1673023)

  • 1. Evidence for a direct pituitary inhibition by free fatty acids of in vivo growth hormone responses to growth hormone-releasing hormone in the rat.
    Alvarez CV; Mallo F; Burguera B; Cacicedo L; Dieguez C; Casanueva FF
    Neuroendocrinology; 1991 Feb; 53(2):185-9. PubMed ID: 1673023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Free fatty acids block growth hormone (GH) releasing hormone-stimulated GH secretion in man directly at the pituitary.
    Casanueva FF; Villanueva L; Dieguez C; Diaz Y; Cabranes JA; Szoke B; Scanlon MF; Schally AV; Fernandez-Cruz A
    J Clin Endocrinol Metab; 1987 Oct; 65(4):634-42. PubMed ID: 2888782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of His-dTrp-Ala-Trp-dPhe-Lys-NH2 (GHRP-6)-induced GH secretion in the rat.
    Mallo F; Alvarez CV; Benitez L; Burguera B; Coya R; Casanueva FF; Dieguez C
    Neuroendocrinology; 1993; 57(2):247-56. PubMed ID: 8510800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acipimox potentiates growth hormone (GH) response to GH-releasing hormone with or without pyridostigmine by lowering serum free fatty acid in normal and obese subjects.
    Lee EJ; Nam SY; Kim KR; Lee HC; Cho JH; Nam MS; Song YD; Lim SK; Huh KB
    J Clin Endocrinol Metab; 1995 Aug; 80(8):2495-8. PubMed ID: 7629249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth hormone (GH)-releasing hormone (GHRH) and the GH secretagogue (GHS), L692,585, differentially modulate rat pituitary GHS receptor and GHRH receptor messenger ribonucleic acid levels.
    Kineman RD; Kamegai J; Frohman LA
    Endocrinology; 1999 Aug; 140(8):3581-6. PubMed ID: 10433214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth hormone (GH) autofeedback on GH response to GH-releasing hormone. Role of free fatty acids and somatostatin.
    Pontiroli AE; Lanzi R; Monti LD; Sandoli E; Pozza G
    J Clin Endocrinol Metab; 1991 Feb; 72(2):492-5. PubMed ID: 1671389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of glucocorticoid treatment and acute passive immunization with growth hormone-releasing hormone and somatostatin antibodies on endogenous and stimulated growth hormone secretion in the male rat.
    Miell J; Corder R; Miell PJ; McClean C; Gaillard RC
    J Endocrinol; 1991 Oct; 131(1):75-86. PubMed ID: 1683888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypothalamic mediated action of free fatty acid on growth hormone secretion in sheep.
    Briard N; Rico-Gomez M; Guillaume V; Sauze N; Vuaroqueaux V; Dadoun F; Le Bouc Y; Oliver C; Dutour A
    Endocrinology; 1998 Dec; 139(12):4811-9. PubMed ID: 9832417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acipimox-mediated plasma free fatty acid depression per se stimulates growth hormone (GH) secretion in normal subjects and potentiates the response to other GH-releasing stimuli.
    Peino R; Cordido F; Peñalva A; Alvarez CV; Dieguez C; Casanueva FF
    J Clin Endocrinol Metab; 1996 Mar; 81(3):909-13. PubMed ID: 8772549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of acute pharmacological reduction of plasma free fatty acids on growth hormone (GH) releasing hormone-induced GH secretion in obese adults with and without hypopituitarism.
    Cordido F; Fernandez T; Martinez T; Peñalva A; Peinó R; Casanueva FF; Dieguez C
    J Clin Endocrinol Metab; 1998 Dec; 83(12):4350-4. PubMed ID: 9851776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of cholinergic muscarinic pathways on the free fatty acid inhibition of GH responses to GHRH in normal men.
    Peñalva A; Gaztambide S; Vazquez JA; Dieguez C; Casanueva FF
    Clin Endocrinol (Oxf); 1990 Aug; 33(2):171-6. PubMed ID: 2225476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired growth hormone secretion in obese subjects is partially reversed by acipimox-mediated plasma free fatty acid depression.
    Cordido F; Peino R; Peñalva A; Alvarez CV; Casanueva FF; Dieguez C
    J Clin Endocrinol Metab; 1996 Mar; 81(3):914-8. PubMed ID: 8772550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deprivation of growth hormone-releasing hormone early in the rat's neonatal life permanently affects somatotropic function.
    Cella SG; Locatelli V; Mennini T; Zanini A; Bendotti C; Forloni GL; Fumagalli G; Arce VM; de Gennaro Colonna V; Wehrenberg WB
    Endocrinology; 1990 Oct; 127(4):1625-34. PubMed ID: 1976092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arginine stimulates growth hormone secretion by suppressing endogenous somatostatin secretion.
    Alba-Roth J; Müller OA; Schopohl J; von Werder K
    J Clin Endocrinol Metab; 1988 Dec; 67(6):1186-9. PubMed ID: 2903866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of in vivo somatotroph desensitization or depletion after 14 days of continuous growth hormone (GH)-releasing hormone administration in normal men and a GH-deficient boy.
    Vance ML; Kaiser DL; Martha PM; Furlanetto R; Rivier J; Vale W; Thorner MO
    J Clin Endocrinol Metab; 1989 Jan; 68(1):22-8. PubMed ID: 2491864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of continuous somatostatin and growth hormone-releasing hormone (GHRH) infusions on the subsequent growth hormone (GH) response to GHRH. Evidence for somatotroph desensitization independent of GH pool depletion.
    Rittmaster RS; Loriaux DL; Merriam GR
    Neuroendocrinology; 1987 Feb; 45(2):118-22. PubMed ID: 2883595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The decrease in growth hormone (GH) response after repeated stimulation with GH-releasing hormone is partly caused by an elevation of somatostatin tonus.
    Reichardt B; Schrader M; Mojto J; Mehltretter G; Müller OA; Schopohl J
    J Clin Endocrinol Metab; 1996 May; 81(5):1994-8. PubMed ID: 8626871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term administration of acipimox potentiates growth hormone response to growth hormone-releasing hormone by decreasing serum free fatty acid in obesity.
    Nam SY; Lee ; Kim KR; Lee HC; Nam MS; Cho JH; Huh KB
    Metabolism; 1996 May; 45(5):594-7. PubMed ID: 8622602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blocked growth hormone-releasing peptide (GHRP-6)-induced GH secretion and absence of the synergic action of GHRP-6 plus GH-releasing hormone in patients with hypothalamopituitary disconnection: evidence that GHRP-6 main action is exerted at the hypothalamic level.
    Popovic V; Damjanovic S; Micic D; Djurovic M; Dieguez C; Casanueva FF
    J Clin Endocrinol Metab; 1995 Mar; 80(3):942-7. PubMed ID: 7883854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of the pituitary-specific transcription factor GHF-1/Pit-1 messenger ribonucleic acid levels by growth hormone-secretagogues in rat anterior pituitary cells in monolayer culture.
    Soto JL; Castrillo JL; Dominguez F; Dieguez C
    Endocrinology; 1995 Sep; 136(9):3863-70. PubMed ID: 7649093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.